AstraZeneca Sues Cancer Research Co. Over License Breach
Pharmaceutical giant AstraZeneca is suing U.S. drugmaker Tesaro Inc. for a "substantial amount" of unpaid royalties it says are due under a license for a blockbuster cancer drug....To view the full article, register now.
Already a subscriber? Click here to view full article